Related Experiment Video
Updated: Aug 9, 2026

Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice
Published on: September 16, 2020
The role of inhibitory molecules in fracture healing
Rozalia Dimitriou1, Eleftherios Tsiridis, Ian Carr
1Academic Department of Trauma & Orthopaedic Surgery, School of Medicine, University of Leeds, United Kingdom.
Abstract:
The balance between all the signalling molecules involved in bone formation with their inhibitors and most importantly between BMPs and their antagonists is critical determinant of osteogenesis, and therefore of skeletal development, fracture repair, and bone remodelling. The main identified inhibitory molecules of the osteogenic lineage, either from studies during embryonic development or from in vitro and in vivo studies are presented in the herein study. Potential treatments using these molecules either alone or in combination with BMPs to control the bone growth and overgrowth are already under investigation aiming in treatments that mimic as much as possible the natural process of bone generation in various situations including fracture healing, osteoporosis, and osteoarthritis and other metabolic disorders, in order to more closely resemble the original tissue.
Insights
Maintaining the balance of bone-signaling molecules, particularly BMPs and their antagonists, is crucial for bone formation. Understanding these inhibitors aids in developing treatments for skeletal disorders and injuries.
Area of Science:
- Biochemistry
- Developmental Biology
- Orthopedics
Background:
- Osteogenesis relies on a delicate balance of signaling molecules, including bone morphogenetic proteins (BMPs) and their inhibitors.
- Dysregulation of these signaling pathways is implicated in various skeletal conditions.
Purpose of the Study:
- To identify key inhibitory molecules affecting osteogenesis.
- To explore therapeutic strategies utilizing these inhibitors for bone regeneration.
Main Methods:
- Review of studies on osteogenic lineage inhibitors during embryonic development.
- Analysis of in vitro and in vivo experimental data.
Main Results:
- Identification of critical inhibitory molecules impacting bone formation.
- Investigation into therapeutic potential of these inhibitors, alone or with BMPs.
Conclusions:
- Understanding BMP antagonists is key to controlling bone growth and regeneration.
- Targeting these inhibitors offers potential for novel treatments in fracture healing, osteoporosis, and osteoarthritis.
Related Concept Videos
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Intracellular Signaling Affects Focal Adhesions
Some...
Healing I: Introduction
Clot Retraction and Fibrinolysis
Bone Remodeling and Repair

